Robert J Terifay Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Robert J Terifay.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Robert J Terifay. Robert J Terifay is EVP Commercial in REGENERON PHARMACEUTICALS INC ($REGN) and SVP Commercial in REGENERON PHARMACEUTICALS INC ($REGN) and SVP, Commercial in REGENERON PHARMACEUTICALS INC ($REGN).
Latest Insider Trading Transactions of Robert J Terifay
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | A | 378.98 | 32,300 | 12,241,054 | 32,300 | |
| Aug 11 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | M | 52.03 | 1,921 | 99,950 | 0 | |
| Aug 11 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Buy | M | 52.03 | 1,921 | 99,950 | 25,214 | 23.3 K to 25.2 K (+8.25 %) |
| Jun 19 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | M | 52.03 | 48,750 | 2,536,463 | 30,579 | |
| Jun 19 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Sell | S | 468.19 | 21,147 | 9,900,814 | 23,293 | 44.4 K to 23.3 K (-47.59 %) |
| Jun 19 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Payment of Exercise | F | 468.69 | 22,192 | 10,401,168 | 44,440 | 66.6 K to 44.4 K (-33.31 %) |
| Jun 19 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Payment of Exercise | F | 468.69 | 5,411 | 2,536,082 | 66,632 | 72 K to 66.6 K (-7.51 %) |
| Jun 19 2017 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Buy | M | 52.03 | 48,750 | 2,536,463 | 72,043 | 23.3 K to 72 K (+209.29 %) |
| Dec 19 2016 | REGN | REGENERON PHARMACE ... | Terifay Robert J | EVP Commercial | Option Exercise | A | 381.92 | 34,000 | 12,985,280 | 34,000 | |
| Dec 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 555.67 | 40,000 | 22,226,800 | 40,000 | |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 29,236 | 895,499 | 0 | |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 3,264 | 99,976 | 0 | |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 593.66 | 800 | 474,928 | 23,293 | 24.1 K to 23.3 K (-3.32 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 592.40 | 23 | 13,625 | 24,093 | 24.1 K to 24.1 K (-0.10 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 591.75 | 957 | 566,305 | 24,116 | 25.1 K to 24.1 K (-3.82 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 590.57 | 2,486 | 1,468,157 | 25,073 | 27.6 K to 25.1 K (-9.02 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 589.76 | 2,542 | 1,499,170 | 27,559 | 30.1 K to 27.6 K (-8.44 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 588.55 | 2,126 | 1,251,257 | 30,101 | 32.2 K to 30.1 K (-6.60 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 587.35 | 2,482 | 1,457,803 | 32,227 | 34.7 K to 32.2 K (-7.15 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 585.22 | 2,007 | 1,174,537 | 34,709 | 36.7 K to 34.7 K (-5.47 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 588.64 | 14,292 | 8,412,843 | 36,716 | 51 K to 36.7 K (-28.02 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 588.64 | 1,521 | 895,321 | 51,008 | 52.5 K to 51 K (-2.90 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 29,236 | 895,499 | 52,529 | 23.3 K to 52.5 K (+125.51 %) |
| Aug 07 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 3,264 | 99,976 | 23,293 | 20 K to 23.3 K (+16.30 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 24,375 | 746,606 | 29,236 | |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 454.00 | 400 | 181,600 | 20,029 | 20.4 K to 20 K (-1.96 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 453.28 | 1,700 | 770,576 | 20,429 | 22.1 K to 20.4 K (-7.68 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 452.61 | 3,200 | 1,448,352 | 22,129 | 25.3 K to 22.1 K (-12.63 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 450.95 | 700 | 315,665 | 25,329 | 26 K to 25.3 K (-2.69 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 450.18 | 2,093 | 942,227 | 26,029 | 28.1 K to 26 K (-7.44 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 448.87 | 300 | 134,661 | 28,122 | 28.4 K to 28.1 K (-1.06 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 448.01 | 2,600 | 1,164,826 | 28,422 | 31 K to 28.4 K (-8.38 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 444.46 | 11,703 | 5,201,515 | 31,022 | 42.7 K to 31 K (-27.39 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 444.46 | 1,679 | 746,248 | 42,725 | 44.4 K to 42.7 K (-3.78 %) |
| Mar 18 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 24,375 | 746,606 | 44,404 | 20 K to 44.4 K (+121.70 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 30.63 | 24,375 | 746,606 | 53,611 | |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 423.67 | 11,173 | 4,733,665 | 20,029 | 31.2 K to 20 K (-35.81 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 427.94 | 11,458 | 4,903,337 | 31,202 | 42.7 K to 31.2 K (-26.86 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 427.94 | 1,744 | 746,327 | 42,660 | 44.4 K to 42.7 K (-3.93 %) |
| Feb 25 2015 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 30.63 | 24,375 | 746,606 | 44,404 | 20 K to 44.4 K (+121.70 %) |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 399.66 | 40,000 | 15,986,400 | 40,000 | |
| Dec 18 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 52.03 | 48,750 | 2,536,463 | 79,329 | |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.25 | 48,750 | 1,035,938 | 0 | |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 408.62 | 1,800 | 735,516 | 20,029 | 21.8 K to 20 K (-8.25 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 407.85 | 2,200 | 897,270 | 21,829 | 24 K to 21.8 K (-9.16 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 406.89 | 3,720 | 1,513,631 | 24,029 | 27.7 K to 24 K (-13.41 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 405.85 | 7,278 | 2,953,776 | 27,749 | 35 K to 27.7 K (-20.78 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 404.75 | 3,252 | 1,316,247 | 35,027 | 38.3 K to 35 K (-8.50 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 403.86 | 2,150 | 868,299 | 38,279 | 40.4 K to 38.3 K (-5.32 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 402.71 | 1,500 | 604,065 | 40,429 | 41.9 K to 40.4 K (-3.58 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 401.42 | 400 | 160,568 | 41,929 | 42.3 K to 41.9 K (-0.94 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 400.45 | 62 | 24,828 | 42,329 | 42.4 K to 42.3 K (-0.15 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 401.75 | 23,810 | 9,565,668 | 42,391 | 66.2 K to 42.4 K (-35.97 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 401.75 | 2,578 | 1,035,712 | 66,201 | 68.8 K to 66.2 K (-3.75 %) |
| Nov 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.25 | 48,750 | 1,035,938 | 68,779 | 20 K to 68.8 K (+243.40 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.25 | 27,795 | 590,644 | 48,750 | |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 333.79 | 2,765 | 922,929 | 20,029 | 22.8 K to 20 K (-12.13 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 332.75 | 6,603 | 2,197,148 | 22,794 | 29.4 K to 22.8 K (-22.46 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 331.66 | 3,497 | 1,159,815 | 29,397 | 32.9 K to 29.4 K (-10.63 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 323.30 | 13,104 | 4,236,523 | 32,894 | 46 K to 32.9 K (-28.49 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 323.30 | 1,826 | 590,346 | 45,998 | 47.8 K to 46 K (-3.82 %) |
| Feb 19 2014 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.25 | 27,795 | 590,644 | 47,824 | 20 K to 47.8 K (+138.77 %) |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.25 | 4,705 | 99,981 | 0 | |
| Dec 19 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.25 | 4,705 | 99,981 | 20,029 | 15.3 K to 20 K (+30.70 %) |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 270.43 | 50,000 | 13,521,500 | 50,000 | |
| Dec 17 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 30.63 | 48,750 | 1,493,213 | 77,986 | |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 2,173 | 36,506 | 0 | |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 14,750 | 247,800 | 2,173 | |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 262.06 | 400 | 104,824 | 15,324 | 15.7 K to 15.3 K (-2.54 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 261.44 | 4,437 | 1,160,009 | 15,724 | 20.2 K to 15.7 K (-22.01 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 260.86 | 3,394 | 885,359 | 20,161 | 23.6 K to 20.2 K (-14.41 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 261.67 | 750 | 196,253 | 23,555 | 24.3 K to 23.6 K (-3.09 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 261.67 | 139 | 36,372 | 24,305 | 24.4 K to 24.3 K (-0.57 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 2,173 | 36,506 | 24,444 | 22.3 K to 24.4 K (+9.76 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 261.67 | 6,857 | 1,794,271 | 22,271 | 29.1 K to 22.3 K (-23.54 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 261.67 | 946 | 247,540 | 29,128 | 30.1 K to 29.1 K (-3.15 %) |
| May 09 2013 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 14,750 | 247,800 | 30,074 | 15.3 K to 30.1 K (+96.25 %) |
| Dec 19 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 5,952 | 99,994 | 0 | |
| Dec 19 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 5,952 | 99,994 | 15,324 | 9.4 K to 15.3 K (+63.51 %) |
| Dec 17 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 179.13 | 75,000 | 13,434,750 | 75,000 | |
| Dec 17 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 21.25 | 48,750 | 1,035,938 | 76,545 | |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 20,000 | 336,000 | 16,923 | |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 175.09 | 2,045 | 358,059 | 9,372 | 11.4 K to 9.4 K (-17.91 %) |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 174.33 | 6,700 | 1,168,011 | 11,417 | 18.1 K to 11.4 K (-36.98 %) |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 173.90 | 1,000 | 173,900 | 18,117 | 19.1 K to 18.1 K (-5.23 %) |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 173.83 | 8,323 | 1,446,787 | 19,117 | 27.4 K to 19.1 K (-30.33 %) |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 173.83 | 1,932 | 335,840 | 27,440 | 29.4 K to 27.4 K (-6.58 %) |
| Nov 26 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 20,000 | 336,000 | 29,372 | 9.4 K to 29.4 K (+213.40 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.92 | 12,500 | 274,000 | 0 | |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 24,375 | 409,500 | 36,923 | |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 16.80 | 14,000 | 235,200 | 61,298 | |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 137.58 | 2,334 | 321,112 | 9,372 | 11.7 K to 9.4 K (-19.94 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 136.26 | 6,600 | 899,316 | 11,706 | 18.3 K to 11.7 K (-36.05 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 135.49 | 14,833 | 2,009,723 | 18,306 | 33.1 K to 18.3 K (-44.76 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 134.99 | 67 | 9,044 | 33,139 | 33.2 K to 33.1 K (-0.20 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 4,839 | 664,830 | 33,206 | 38 K to 33.2 K (-12.72 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 1,994 | 273,956 | 38,045 | 40 K to 38 K (-4.98 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.92 | 12,500 | 274,000 | 40,039 | 27.5 K to 40 K (+45.39 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 9,856 | 1,354,116 | 27,539 | 37.4 K to 27.5 K (-26.36 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 2,980 | 409,422 | 37,395 | 40.4 K to 37.4 K (-7.38 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 24,375 | 409,500 | 40,375 | 16 K to 40.4 K (+152.34 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 5,661 | 777,765 | 16,000 | 21.7 K to 16 K (-26.13 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 137.39 | 1,711 | 235,074 | 21,661 | 23.4 K to 21.7 K (-7.32 %) |
| Jul 31 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 16.80 | 14,000 | 235,200 | 23,372 | 9.4 K to 23.4 K (+149.38 %) |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.92 | 23,128 | 506,966 | 12,500 | |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 91.04 | 900 | 81,936 | 9,372 | 10.3 K to 9.4 K (-8.76 %) |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 90.54 | 8,539 | 773,121 | 10,272 | 18.8 K to 10.3 K (-45.39 %) |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 90.07 | 8,061 | 726,054 | 18,811 | 26.9 K to 18.8 K (-30.00 %) |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 90.07 | 5,628 | 506,914 | 26,872 | 32.5 K to 26.9 K (-17.32 %) |
| Feb 02 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.92 | 23,128 | 506,966 | 32,500 | 9.4 K to 32.5 K (+246.78 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.92 | 1,872 | 41,034 | 35,628 | |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 18,128 | 386,852 | 0 | |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 74.20 | 9,019 | 669,210 | 9,372 | 18.4 K to 9.4 K (-49.04 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 73.92 | 543 | 40,139 | 18,391 | 18.9 K to 18.4 K (-2.87 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 73.92 | 554 | 40,952 | 18,934 | 19.5 K to 18.9 K (-2.84 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.92 | 1,872 | 41,034 | 19,488 | 17.6 K to 19.5 K (+10.63 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 73.92 | 4,651 | 343,802 | 17,616 | 22.3 K to 17.6 K (-20.89 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 73.92 | 5,233 | 386,823 | 22,267 | 27.5 K to 22.3 K (-19.03 %) |
| Jan 11 2012 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 18,128 | 386,852 | 27,500 | 9.4 K to 27.5 K (+193.43 %) |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 52.03 | 30,579 | 1,591,025 | 30,579 | |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 16.80 | 48,750 | 819,000 | 75,298 | |
| Dec 20 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 52.03 | 1,921 | 99,950 | 1,921 | |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 20,000 | 426,800 | 18,128 | |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 9,372 | 199,998 | 0 | |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 65.34 | 6,812 | 445,096 | 9,372 | 16.2 K to 9.4 K (-42.09 %) |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 64.98 | 402 | 26,122 | 16,184 | 16.6 K to 16.2 K (-2.42 %) |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 9,372 | 199,998 | 16,586 | 7.2 K to 16.6 K (+129.91 %) |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 64.78 | 6,198 | 401,506 | 7,214 | 13.4 K to 7.2 K (-46.21 %) |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Payment of Exercise | F | 64.78 | 6,588 | 426,771 | 13,412 | 20 K to 13.4 K (-32.94 %) |
| Oct 11 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 20,000 | 426,800 | 20,000 | 0 to 20 K |
| Mar 07 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.92 | 6,099 | 133,690 | 37,500 | |
| Mar 07 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 38.00 | 6,099 | 231,762 | 0 | 6.1 K to 0 (-100.00 %) |
| Mar 07 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.92 | 6,099 | 133,690 | 6,099 | 0 to 6.1 K |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.92 | 6,401 | 140,310 | 43,599 | |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 38,128 | 813,652 | 38,128 | |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 4,372 | 93,298 | 9,372 | |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 38.00 | 6,401 | 243,238 | 0 | 6.4 K to 0 (-100.00 %) |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.92 | 6,401 | 140,310 | 6,401 | 0 to 6.4 K |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 38.00 | 38,128 | 1,448,864 | 0 | 38.1 K to 0 (-100.00 %) |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 38,128 | 813,652 | 38,128 | 0 to 38.1 K |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 38.00 | 4,372 | 166,136 | 0 | 4.4 K to 0 (-100.00 %) |
| Feb 18 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 4,372 | 93,298 | 4,372 | 0 to 4.4 K |
| Feb 16 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | M | 21.34 | 5,000 | 106,700 | 13,744 | |
| Feb 16 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Sell | S | 37.02 | 5,000 | 185,100 | 0 | 5 K to 0 (-100.00 %) |
| Feb 16 2011 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Buy | M | 21.34 | 5,000 | 106,700 | 5,000 | 0 to 5 K |
| Dec 20 2010 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 30.63 | 29,236 | 895,499 | 29,236 | |
| Dec 20 2010 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 30.63 | 3,264 | 99,976 | 3,264 | |
| Dec 22 2009 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 21.25 | 27,795 | 590,644 | 27,795 | |
| Dec 22 2009 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP Commercial | Option Exercise | A | 21.25 | 4,705 | 99,981 | 4,705 | |
| Dec 19 2008 | REGN | REGENERON PHARMACE ... | Terifay Robert J | SVP, Commercial | Option Exercise | A | 16.80 | 26,548 | 446,006 | 26,548 |